Quartz92d agobullish
Moderna stock surges on hantavirus vaccine, flu trial dataThe company confirmed early-stage hantavirus research as a WHO-confirmed outbreak grows, while flu vaccine data published in a top medical journal
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
361last 24h
2355last 7d
424● bullish (7d)
221● bearish (7d)
202publishers
Barrons.com92d agoneutral
Trump Knows AI Matters More to Markets Than Iran. His China Trip Is Crucial.President rejects Iran’s response, Warsh’s favored inflation measure, airlines are raising bag fees, and more news to start your day.
Investing.com96d agobullish
Moderna stock jumps 10% amid hantavirus outbreak concernsInvesting.com -- Moderna (NASDAQ:MRNA) shares climbed 10% on Thursday as concerns mounted over a hantavirus outbreak connected to a cruise ship.
Barrons.com98d agobullish
Pfizer Stock Edges Higher as Earnings and Revenue Beat EstimatesPfizer shares rose slightly in premarket trading after the company delivered a first-quarter earnings beat and reaffirmed its full-year outlook. The drugmaker posted adjusted earnings of 75 cents a share, ahead of the 72 cents Wall Street had forecast. Pfizer reaffirmed its full-year guidance, which it initially provided in December.